Novel Antipsychotics: Ulotaront (TAAR1 A...

<p>Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford University. He has had extensive research particularly in the field of neuroendocrinology and chronic stress, whic ... Show More

<p>One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners.</p><p><br></p><p><strong>References: </strong></p><ul><li><p><a href="https://pmc.ncb ... Show More

Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications. https://www.ncbi.nlm.nih.gov/books/NBK538165/https://pmc.ncbi.nlm.nih.gov/articles/PMC6769182/ h ... Show More

In the third episode of our “Art of Psychiatry” series, we will discuss schizophrenia, a chronic mental illness that affects 1% of the population. We will focus especially on the patient experience of what it’s like to live with schizophrenia. We’ll start by reviewing the key sym ... Show More

<p dir="ltr"><strong>Contributors:</strong> Andrew White MD & Travis Barlock MD</p> <p dir="ltr">In this follow-up episode Dr. Andrew White, a practicing psychiatrist with an addiction medicine fellowship, and Dr. Travis Barlock, an emergency physician at Swedish Medical Center, ... Show More

In this episode, we are joined by a panel of experts to discuss treatment of psychosis. Experiences of psychosis are common. When these experiences lead to interference in achieving life goals and/or distress, individuals can benefit from seeking evidenced-based care. The earlier ... Show More

Dr Matthew Broome discusses what is known about predicting the risk of transition to psychosis in high risk groups Senior Clinical Research Fellow Matthew Broome discusses what is known about predicting future psychotic conditions such as schizophrenia or bipolar. He discusses th ... Show More

Treatment for schizophrenia is a tough journey for people with the illness but also for caregivers and loved ones. Due to cognitive symptoms, hallucinations, and delusions, a person with schizophrenia may not be able to make decisions on treatment or take care of themselves. When ... Show More

<strong>Substance-Induced Psychosis (Part I)</strong>   <p><span style="font-weight: 400;">In this first episode of a two-part mini-series, we feature Dr. Nadia Haddad, a Colorado psychiatrist, and Dr. Ricky Dhaliwal, an emergency medicine physician, as they discuss the different ... Show More

Today's episode includes the first half of the Psychiatry chapter from Crush Step 1, covering: - Psychology and Development (Theories of Learning & Miscellaneous Concepts) - Psychopathology Psychiatric Disorders of Children Delirium v. Dementia Schizophrenia & Similar Disorders D ... Show More

<p>Aujourd'hui on parle de psychogénéalogie avec la thérapeute certifiée Laura Chirco. Sur le podcast de Psychologue.net, nous nous dédions à donner des pistes et à résoudre des problèmes du quotidien pour améliorer votre bien-être et votre santé mentale. &nbsp;&nbsp;</p> <p>Retr ... Show More

Interview with Marcel Riehle, PhD, author of Emotional Experience of People With Schizophrenia and People at Risk for Psychosis: A Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Emotional Experience of People With Schizophrenia and People at Risk for Psychosis